Previously, the company projected earnings per diluted share of $12.50 to $13, but the update range is $12.60 to $12.90.
Additionally, McKesson shared preliminary fiscal 2017 adjusted earnings per diluted share growth of 7 percent to 12 percent.
More articles on health IT:
Allscripts, Medfusion settle breach of contract dispute
Nurses benefit from telemedicine in the ICU: 5 survey findings
6 recent vendor contracts, go-lives
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
